The gut microbiome and pathology of Alzheimer’s disease

Abstract Background Current literature focuses on the association between gut dysbiosis and the aggregation of Aβ, the development of tau protein, as well as neuroinflammation and oxidative stress associated with AD. Since the brain and gut are connected (gut‐brain axis), gut microbiota and their metabolites may influence AD progression, or vice versa, if AD pathogenesis impacts the microbiome. Observational studies have shown an altered taxonomic composition of gut microbiota in AD patients compared to cognitively normal (CN) controls. Method This perspective study will explore taxonomic composition and gut microbial function (using metagenomic analysis) compared with Aβ aggregation, deposition of tau, and inflammatory biomarkers in cognitively normal individuals and preclinical AD individuals. We will also address the effect of dietary intake on gut dysbiosis to assess the effectiveness of healthy diet patterns as preventive approaches in AD. Results The faecal samples of people with AD have been shown to have decreased microbial diversity and compositionally distinct microbiota. At the same time, correlations were found between gut microbiome differences and cerebrospinal fluid (CSF) tau levels, and plasma β‐amyloid (Aβ) biomarkers levels early in the progression of the disease. However, research into the gut and brain concerning AD progression and AD pathology remains very inconsistent with the reported data. Therefore, evaluation of the potential role of microbiota taxonomy in stool in the early detection of preclinical AD may lead to the development of novel directions in the investigation of the potential role of the gut in AD progression. Conclusion The altered gut microbiota can influence increased Aβ deposits, tau phosphorylation, and neuroinflammation. Therefore, it is necessary to gain a better understanding of microbial community diversity at the species level and the function of these communities due to AD pathology as well as the effect of confounding factors like dietary intake.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-01
DOI
https://doi.org/10.1002/alz.090732
Citations
1
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.23
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The gut microbiome and pathology of Alzheimer’s disease

Stephanie R. Rainey‐Smith, Ralph N. Martins, Warnakulasuriya Mary Ann Dipika Binosha Fernando, Sithara Udeshini Dissanayaka
1 citations
Alzheimer s & Dementia
Gut microbiota and health
0.23
article

The gut microbiome and pathology of Alzheimer’s disease

Stephanie R. Rainey‐Smith, Ralph N. Martins, Warnakulasuriya Mary Ann Dipika Binosha Fernando, Sithara Udeshini Dissanayaka
article en
1 citations

Abstract

Abstract Background Current literature focuses on the association between gut dysbiosis and the aggregation of Aβ, the development of tau protein, as well as neuroinflammation and oxidative stress associated with AD. Since the brain and gut are connected (gut‐brain axis), gut microbiota and their metabolites may influence AD progression, or vice versa, if AD pathogenesis impacts the microbiome. Observational studies have shown an altered taxonomic composition of gut microbiota in AD patients compared to cognitively normal (CN) controls. Method This perspective study will explore taxonomic composition and gut microbial function (using metagenomic analysis) compared with Aβ aggregation, deposition of tau, and inflammatory biomarkers in cognitively normal individuals and preclinical AD individuals. We will also address the effect of dietary intake on gut dysbiosis to assess the effectiveness of healthy diet patterns as preventive approaches in AD. Results The faecal samples of people with AD have been shown to have decreased microbial diversity and compositionally distinct microbiota. At the same time, correlations were found between gut microbiome differences and cerebrospinal fluid (CSF) tau levels, and plasma β‐amyloid (Aβ) biomarkers levels early in the progression of the disease. However, research into the gut and brain concerning AD progression and AD pathology remains very inconsistent with the reported data. Therefore, evaluation of the potential role of microbiota taxonomy in stool in the early detection of preclinical AD may lead to the development of novel directions in the investigation of the potential role of the gut in AD progression. Conclusion The altered gut microbiota can influence increased Aβ deposits, tau phosphorylation, and neuroinflammation. Therefore, it is necessary to gain a better understanding of microbial community diversity at the species level and the function of these communities due to AD pathology as well as the effect of confounding factors like dietary intake.

Alzheimer s & DementiaVol. 20(S7)
Edith Cowan University (AU), Murdoch University (AU), Dementia Australia (AU), Macquarie University (AU)
Openalex Percentile: Top 40%
Gut microbiota and health
0.23
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.